Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Menold Daniel. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. Cumulatively, 7 filings have been published. History available since 9 August 2023. The latest transaction was disclosed on 16 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
10,000 shares@ US$4.0512.6% of flowCommon StockSEC:0001062993-24-000924:0
10,000 shares@ US$4.0512.6% of flowCommon StockSEC:0001062993-23-022638:0
17,500 shares@ US$3.4519.0% of flowCommon StockSEC:0001062993-23-021138:0
17,500 shares@ US$3.4519.5% of flowCommon StockSEC:0001062993-23-019548:0
1,545 shares@ US$1.821.2% of flowCommon StockSEC:0001062993-23-018279:0
8,500 shares@ US$1.062.8% of flowCommon StockSEC:0001062993-23-016607:0
20,945 shares@ US$5.0032.6% of flowCommon StockSEC:0001062993-23-016299:0